Distinct Lysosomal Network Protein Profiles in Parkinsonian Syndrome Cerebrospinal Fluid. - Test2 - elhamkhani - TriplyDB

Distinct Lysosomal Network Protein Profiles in Parkinsonian Syndrome Cerebrospinal Fluid.

Distinct Lysosomal Network Protein Profiles in Parkinsonian Syndrome Cerebrospinal Fluid.

http://www.wikidata.org/entity/Q37054024

about

Recent developments in circulating biomarkers in Parkinson's disease: the potential use of miRNAs in a clinical setting.Cerebrospinal Fluid Concentration of Key Autophagy Protein Lamp2 Changes Little During Normal Aging.

P2860

Q39010887-5309570E-1599-4EF3-81D9-D99F98942017 Q54965160-BB7F5170-7ED6-4390-8FA6-C6F5FF74ED31

P2860

Distinct Lysosomal Network Protein Profiles in Parkinsonian Syndrome Cerebrospinal Fluid.

http://www.wikidata.org/entity/Q37054024

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 02 April 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Distinct Lysosomal Network Protein Profiles in Parkinsonian Syndrome Cerebrospinal Fluid.

@en

Distinct Lysosomal Network Protein Profiles in Parkinsonian Syndrome Cerebrospinal Fluid.

@nl

type

label

Distinct Lysosomal Network Protein Profiles in Parkinsonian Syndrome Cerebrospinal Fluid.

@en

Distinct Lysosomal Network Protein Profiles in Parkinsonian Syndrome Cerebrospinal Fluid.

@nl

prefLabel

Distinct Lysosomal Network Protein Profiles in Parkinsonian Syndrome Cerebrospinal Fluid.

@en

Distinct Lysosomal Network Protein Profiles in Parkinsonian Syndrome Cerebrospinal Fluid.

@nl

P1433

Q37054024-FCCB3B04-0F8A-48D2-B9D9-071321880F7C

P1476

Q37054024-947D7364-34AC-499E-8D51-23A0EDA67DDE

P2093

Q37054024-0BCB24F5-191D-4281-AEBE-4CEB9C41BC08

Q37054024-1B910828-676F-4CF5-BEB7-C96A1C3B916D

Q37054024-4CEA63FF-330B-4831-9D1D-E49F99189ACB

Q37054024-8EDBB059-9FE9-460B-B037-6596B72F9216

Q37054024-C3175B2C-1027-434C-A4DA-866741286AEC

Q37054024-D5D394D5-098C-4FDF-9CBE-25B35DFFB988

Q37054024-FD77E9FE-49A6-4F0A-BFDE-2E793162CFE4

P2860

Q37054024-14CD2ED5-ED24-42A2-B7CA-EF3E121537FD

Q37054024-2996F3C8-5E42-4C29-9420-60659A761187

Q37054024-3BC6E2AC-D4CA-4B45-9257-025DF762E3B2

Q37054024-3E086589-1EFC-4F3D-8FD2-4D364A2656C2

Q37054024-4CEB230B-9FE4-4A26-B254-23FABCAF813B

Q37054024-55867318-187E-4BE1-B946-DBA92F9669FE

Q37054024-61D0744D-21BA-401B-8368-237DB4053CC7

Q37054024-63393528-6C55-4501-8859-D08C134C5DCE

Q37054024-724ABF7C-131A-48F7-ACD6-A6BB36B12737

Q37054024-74746C14-040D-4587-93BB-A928884FF576

P304

Q37054024-304B0B96-42EF-48CE-BD5E-4D439761E5B2

P31

Q37054024-04461168-80FA-4699-9442-712F9BE64C01

P356

Q37054024-DE88CE3E-FA79-4077-92FC-F0006E535AE6

P433

Q37054024-3D6EEB85-EB0C-4D9D-B73E-C9808BC14451

P478

Q37054024-B8B170BB-3B58-4DBC-B600-B1EBF5C5E476

P50

Q37054024-1F1C8CA1-87E7-4E38-8616-837781B71904

Q37054024-E9B59780-94B1-4ED3-A0F3-87517E0446BE

P577

Q37054024-BB3F81A0-71C4-4F0F-8F95-9E26F19ED83C

P698

Q37054024-A6AAC1E6-9FA0-44B0-8442-56C20C60C072

P921

Q37054024-B639D9BD-3454-458F-8DE5-14A33552806B

Q37054024-E0B269F8-EDA8-416A-B85B-A50C646E23FA

P932

Q37054024-47E7F104-9EDB-44C4-9350-EF0A89573F33

P356

P1433

Journal of Parkinson's disease

P1476

Distinct Lysosomal Network Protein Profiles in Parkinsonian Syndrome Cerebrospinal Fluid.

@en

P2093

Andrea Boman

http://www.w3.org/2001/XMLSchema#string

Anna Karydas

http://www.w3.org/2001/XMLSchema#string

Bruce Miller

http://www.w3.org/2001/XMLSchema#string

Julio C Rojas

http://www.w3.org/2001/XMLSchema#string

Katarina Kågedal

http://www.w3.org/2001/XMLSchema#string

Per Svenningsson

http://www.w3.org/2001/XMLSchema#string

Samuel Svensson

http://www.w3.org/2001/XMLSchema#string

P2860

Reduced glucocerebrosidase is associated with increased α-synuclein in sporadic Parkinson's disease

Chaperone-mediated autophagy markers in Parkinson disease brains

Distribution of astrocytic plaques in the corticobasal degeneration brain and comparison with tuft-shaped astrocytes in the progressive supranuclear palsy brain

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases

Cerebrospinal fluid biomarkers in parkinsonian conditions: an update and future directions

α-Synucleinopathy phenotypes.

Lewy bodies in progressive supranuclear palsy represent an independent disease process.

Neuropathology of variants of progressive supranuclear palsy.

Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop.

Expression of mutant alpha-synuclein modulates microglial phenotype in vitro

P304

307-315

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3233/JPD-150759

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-04-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27061067

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

cerebrospinal fluid

P932

4927933

http://www.w3.org/2001/XMLSchema#string